Products Categories

Cetyl Salicylic Acid; Aspir...

Agilent Analytical Laborato...

Lefamulin Acetate CAS No. 1...

Gatifloxacin Mesylate CAS N...

Gatifloxacin CAS No. 112811...

Flumequine Sodium CAS No. 4...

Flumequine CAS No. 42835-25...

Florfenicol CAS No. 73231-3...

Finasteride CAS No. 98319-2...

Enrofloxacin HCL CAS No. 11...

0102030405

IMATINIB MESYLATE Intermediates CAS No 106261-49-8 Pharmaceutical Intermediates

Product Name	IMATINIB MESYLATE Intermediates
Other Name	4-[(4-METHYLPIPERAZIN-1-YL)METHYL]BENZOIC ACID DIHYDROCHLORIDE
CAS No.	106261-49-8
EINECS	604-858-2
Formula	C13H20Cl2N2O2
Molecular Weight	307.22
Appearance	White to Almost white powder to crystal
Purity	≥98%
Type	Pharmaceutical Intermediates

Innovative pharmaceutical intermediate: 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride is a novel compound with great potential in drug development, especially in the treatment of various diseases.

High Purity & Quality: Produced in our state-of-the-art facility to ensure the highest pharmaceutical standards.

Integrated Production and Trading: As a production and trading integrated factory, we provide competitive prices and reliable supply chain solutions.

Regulatory Compliance: Our products meet all necessary regulatory requirements to ensure safety and efficacy in pharmaceutical applications.

Research-Backed Efficacy: Backed by extensive research, this compound shows great potential in a variety of therapeutic applications.

product details

Product details

138982-67-9 ZIPRASIDONE HYDROCHLORIDE 外包装3

Product detail

4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride is a special compound that plays a vital role in the pharmaceutical industry. Its unique structure makes it an important intermediate in the synthesis of various pharmaceutical agents. This compound is particularly well known for its use in the development of drugs targeting a range of medical conditions, including neurological disorders and other therapeutic areas. The presence of the piperazine moiety enhances its reactivity and versatility, making it a valuable building block in medicinal chemistry.

product detail

CAS No.	40856-44-8
EINECS	609-874-3
Formula	C9H11NO2
Molecular Weight	165.19
Appearance	White to Off-White solid
Purity	≥98%
Type	Pharmaceutical Intermediates

Physical and Chemical Properties

4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride possesses unique physical and chemical properties that contribute to its effectiveness as a pharmaceutical agent.

- Molecular formula: C13H20Cl2N2O2

- Molecular weight: 307.22 g/mol

- Appearance: White to Almost white powder to crystal

- Solubility: Soluble in water and organic solvents such as methanol and dimethyl sulfoxide (DMSO)

- Melting point: approx. 180-185 °C

- Stability: Stable under normal storage conditions for the recommended shelf life, ensuring long-term efficacy.

These properties not only enhance the performance of the compounds but also facilitate their formulation into various pharmaceutical products including tablets, capsules, and injections.

Advantages

The benefits of 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride are not limited to its chemical composition. Here are some of the key advantages that make it a top choice in the pharmaceutical industry:

1. Targeted Therapeutic Applications: The unique structure of this compound can interact with specific biological pathways in a targeted manner, thereby enhancing its effectiveness in treating various diseases, especially neurology and oncology.

2. Enhanced reactivity: The presence of the piperazine group increases the reactivity of the compound, making it suitable for a wide range of chemical reactions and medicinal chemistry applications.

3. Improved bioavailability: The chemical properties of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride help improve absorption and bioavailability in the body, thereby achieving better therapeutic effects when used in pharmaceutical formulations.

4. Research Driven Development: After extensive research, this compound has shown good promise in various therapeutic areas, making it a valuable addition to any drug portfolio.

5. Full Support: Our integrated factory model ensures that we provide not only products but also full support, including technical assistance and regulatory guidance.

Committed to Quality and Compliance

As a factory integrating production and trading, we are proud of our commitment to quality and compliance. Our manufacturing process follows Good Manufacturing Practice (GMP), ensuring that each batch of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride meets strict quality standards. From raw materials to finished products, we conduct rigorous testing at every stage of production to ensure safety and effectiveness.

Our factory is equipped with advanced technology and staffed by a team of experienced professionals dedicated to maintaining the highest level of quality control. We understand the critical nature of pharmaceutical products and are committed to providing the best products to our customers.

In summary

In summary, 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride represents a significant advancement in drug development. With its unique physical and chemical properties, proven efficacy, and our commitment to quality, it is a leading choice in the pharmaceutical industry. As a factory integrating production and trading, we are capable of meeting the growing demand for this essential compound, ensuring that healthcare providers and patients have access to the best treatment options. Choose 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride for reliable, effective solutions for pharmaceutical applications.